News ODI Pharma AB

Equities

ODI

SE0013409760

End-of-day quote NORDIC GROWTH MARKET Other stock markets 18:00:00 2024-05-14 EDT			5-day change	1st Jan Change
7.6 ^SEK	-1.30%		+7.04%	+52.00%

05-02	ODI Pharma AB Provides Sales Guidance for the Third Quarter of the Year 2024	CI
02-22	ODI Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Preliminary results for ODI Pharma indicate significant revenue increase in Q3 2023/2024	05-02	AQ
ODI Pharma AB Provides Sales Guidance for the Third Quarter of the Year 2024	05-02	CI
ODI Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	02-22	CI
Announcement from the Annual General Meeting in ODI Pharma AB (publ)	12-15	AQ
ODI Pharma Sells CBD Skincare Brand for SEK3 Million	12-06	MT
ODI Pharma AB announces sale of the skincare brand kandol. for 3.2 msek	12-06	AQ
ODI Pharma AB publishes the annual report for the fiscal year 2022/2023	11-24	AQ
ODI Pharma AB Reports Earnings Results for the First Quarter Ended September 30, 2023	11-24	CI
ODI Pharma AB postpones publication of interim report and annual report until November 24, 2023	11-23	AQ
Notice to Annual General Meeting in ODI Pharma AB (publ)	11-13	AQ
ODI Pharma AB: Publication of year-end report for the fiscal year 2022/2023	23-08-24	AQ
ODI Pharma AB Reports Earnings Results for the Fourth Quarter and Full Year Ended June 30, 2023	23-08-24	CI
ODI Pharma’s Stock Soars After Exclusive Supplier Deal With Synoptis Pharma	23-08-07	MT
ODI Pharma AB enters into exclusive collaboration with Synoptis Pharma Sp. z o.o.	23-08-07	AQ
ODI Phaa AB Enters into Exclusive Collaboration with Synoptis Pharma Sp. Z o.o	23-08-07	CI
ODI Pharma AB receives loan financing of EUR 350,000	23-06-01	AQ
ODI Pharma AB Receives Loan Financing of EUR 350,000	23-06-01	CI
ODI Pharma AB: Publication of interim report report Q3 2022/2023	23-05-25	AQ
ODI Pharma AB Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	23-05-25	CI
ODI Pharma AB: Publication of half-year report 2022/2023	23-02-23	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News ODI Pharma AB

Equities

ODI

SE0013409760

Summary

Filters